Description
HER2/neu (654-662) is a peptide fragment of the HER2/neu receptor, also known as CD340, EGFR2, or erbB2. This receptor exhibits anti-apoptotic activity and is associated with breast and other cancers.
Product Unit Size | Cost | Quantity | Stock |
---|
HER2/neu (654-662) is a peptide fragment of the HER2/neu receptor, also known as CD340, EGFR2, or erbB2. This receptor exhibits anti-apoptotic activity and is associated with breast and other cancers.
Purity | ≥95% |
---|---|
Formula | C42H77N9O11 |
Formula Wt. | 884.12 |
Synonym | ErbB2, EGFR2, CD340 |
Solubility | Soluble in DMSO, DMF, acetonitrile. |
Appearance | White to off white powder |
Store Temp | -20°C |
---|---|
Ship Temp | Ambient |
Info Sheet |
---|
Mitri Z, Constantine T, O'Regan R. The HER2 Receptor in Breast Cancer: Pathophysiology, Clinical Use, and New Advances in Therapy. Chemother Res Pract. 2012;2012:743193. PMID: 23320171.
Roy V, Perez EA. Beyond trastuzumab: small molecule tyrosine kinase inhibitors in HER-2-positive breast cancer. Oncologist. 2009 Nov;14(11):1061-9. PMID: 19887469.
Synthetic compound related to sulforaphane.
α2-adrenergic and imidazoline-1 antagonist, AT...
Dihydropyridine; L-type Ca2+ channel blocker.
D2/3 agonist.
Macrolide antibiotic; vacuolar H+ ATPase inhibi...
Polycyclic aromatic hydrocarbon (PAH) found in ...
NSAID; COX-2 inhibitor.
Nitroimidazole; hypoxic modifier and radiosensi...
PDK1 inhibitor.
Produced by various marine proteobacteria
Endogenous steroid hormone, estradiol metabolit...
Aminoglycoside; protein translation inhibitor.<...
Non-depolarizing NMJ blocker; nAChR antagonist....
Endogenous opioid peptide; μOR agonist.
CDK4/6 inhibitor.
Endogenous tachykinin peptide, involved in infl...
NSAID; COX-1/2 inhibitor.
CDK inhibitor.
Inhibits NS5A
Camptothecin derivative; topoisomerase I inhibi...